Accel Diagnostics services

ADX Diagnostic lab offers multiple types of COVID-19 tests: RT-PCR testing, Antigen, and Antibody, and the newly released Quantitative Antibody Tests. We offer expedited (2hr) PCR, Same-Day PCR, Next-Day PCR, and Rapid Antigen and Antibody Tests. We accept self-pay, insurance-covered, and uninsured patients (Government Uninsured Program).

Leveraging the ADX Technology, we have developed a set of rapid assays (DNA-q Card, RapidQ Ms-IgG Assay) to support laboratory research. These tests enable researchers to quickly and efficiently quantify the concentration of biomolecules in their samples prior to moving to downstream processes.

Our quantitative SARS-CoV-2 (COVID-19) IgG antibody test is designed to measure the level of the IgG antibodies against the Spike protein of SARS-COV-2 virus - the virus that causes COVID-19. Unlike most antibody tests, which provide a positive/negative response, the ADX Diagnostic Lab’s antibody test provides you with a numerical value that indicates the antibody level. Therefore making it possible to follow the increase and/or decline of the antibodies either after an infection or vaccination.

A comprehensive Molecular Fungal Infection Panel. It detects 19 fungal and 2 bacterial pathogens including ABX Resistant Markers. ADX Diagnostic Lab understands the pressing need to quickly identify the pathogens and underlying causes of disease.

This Molecular PCR panel with Antibiotic Resistance Markers is designed to rapidly identify organisms that are frequent causes of Urinary Tract Infection in patients with clinical signs and symptoms of UTI. Antibiotic Resistance Markers are included to assist with rapid antibiotic selection. It identifies pathogens difficult to grow in culture and use the largest pathogen menu available. Testing has a high sensitivity and specificity compared to the traditional urine culture technique. It minimizes false negatives while promoting antibiotic stewardship.